Balance Sheet Data

Taro Pharmaceutical Industries Ltd. (TARO)

$42.06

-0.07 (-0.17%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 1,049.331,108.741,023.66820.75850.29894.68862.73831.92802.20773.55
Total Cash (%)
Account Receivables 285.31270.79266.89306.70259.47257.60248.40239.53230.97222.72
Account Receivables (%)
Inventories 148.08153.07180.29210.44226.67172.09165.94160.01154.30148.79
Inventories (%)
Accounts Payable 35.0628.8661.1768.2368.4849.6847.9046.1944.5442.95
Accounts Payable (%)
Capital Expenditure -30.68-28.39-17.14-12.04-17.85-19.19-18.50-17.84-17.21-16.59
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.